HomeSARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19 June 30, 2021 print this article SARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19 Nader et al.; PLoS One. 2021 Jun 23;16(6):e0253347